{
      "Rank": 330,
      "Acronym": [],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "After implementing PCI, contemporary drug treatment is conducted.\n\n*Contemporary drug treatment is a general drug treatment (Unfractionated heparin, Low Molecular Weight Heparin, Glycoprotein llb/llla inhibitor, Aspirin, clopidogrel or Ticlopidine, Nitrate, ACE inhibitor or ARB, \u03b2-blocker, CCB, Diuretics, Statin, etc.)",
            "Within 30 days (+ / -7 days) after aspirating bone-marrow, approximately 1\u00d710^6/kg (refer to usage/dosage according to mass) of autologous bone marrow-derived mesenchymal stem cells are adminstered into the infarct coronary artery using balloon tipped catheter. Furthermore, contemporary drug treatment is conducted."
      ],
      "ArmGroupInterventionName": [
            "Biological: Hearticellgram-AMI"
      ],
      "ArmGroupLabel": [
            "Control",
            "Single dose of Hearticellgram-AMI"
      ],
      "ArmGroupType": [
            "No Intervention",
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT01652209"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Through the injection of Hearticellgram-AMI into acute myocardial infarction patients who are the primary targets of the drug, long term efficacy in the improvement of the left ventricle ejection fraction upon the first cell treatment is to be evaluated and compared with the current existing treatments (contemporary drug treatment).\n\nThis study will also compare the efficacy and safety of single dose of hearticellgram-AMI."
      ],
      "BriefTitle": [
            "To Evaluate the Efficacy and Safety of Hearticelgram\u00ae-AMI in Patients With Acute Myocardial Infarction."
      ],
      "CentralContactEMail": [
            "jyjeong@pharmicell.com"
      ],
      "CentralContactName": [
            "JIYEOUN JEONG",
            "Jeonghan Yoon, Ph.D. M.D."
      ],
      "CentralContactPhone": [
            "82-2-3496-0134"
      ],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [
            "Contact",
            "Contact"
      ],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "December 31, 2023"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Acute Myocardial Infarction"
      ],
      "ConditionAncestorId": [
            "D000007511",
            "D000010335",
            "D000009336",
            "D000017202",
            "D000006331",
            "D000002318",
            "D000014652"
      ],
      "ConditionAncestorTerm": [
            "Ischemia",
            "Pathologic Processes",
            "Necrosis",
            "Myocardial Ischemia",
            "Heart Diseases",
            "Cardiovascular Diseases",
            "Vascular Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC14",
            "BC23",
            "All",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Heart and Blood Diseases",
            "Symptoms and General Pathology",
            "All Conditions",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Myocardial Infarction",
            "Infarction"
      ],
      "ConditionBrowseLeafId": [
            "M11307",
            "M9434",
            "M9695",
            "M11436",
            "M5698",
            "M18658",
            "M8571",
            "M16552",
            "T170"
      ],
      "ConditionBrowseLeafName": [
            "Myocardial Infarction",
            "Infarction",
            "Ischemia",
            "Necrosis",
            "Coronary Artery Disease",
            "Myocardial Ischemia",
            "Heart Diseases",
            "Vascular Diseases",
            "Acute Graft Versus Host Disease"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000009203",
            "D000007238"
      ],
      "ConditionMeshTerm": [
            "Myocardial Infarction",
            "Infarction"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "We are enrolling a patient who had successful conventional percutaneous coronary intervention after acute myocardial infarction. Patients are allocated to one of three groups (group1=comparator, group2= one dose of hearticellgram-AMI).\n\nsingle dose of hearticellgram-AMI have been attained new drug approval from MFDS (related to NCT01392105)."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nAs of the date of written consent, between 20 and 75 years of age\nThose with less than 50% of the left ventricular ejection fraction (LVEF) on echocardiography performed after percutaneous coronary intervention (PCI) (evaluated by investigator)\n\nWho has been identified as an acute myocardial infarction in any of the following on an electrocardiogram (12-lead electrocardiography, ECG) performed before PCI\n\nST-segment elevation 0.1 mV in two or more limb leads or\n0.2 mV elevation in two or more contiguous precordial leads indicative of acute myocardial infarction (AMI)\nThose identified as anterior wall MI\nWho meet the above criteria and have successfully reperfused within 72 hours after the onset of chest pain\nWho can conduct clinical trials according to the clinical trial protocol\nWho has consented in writing to voluntarily participate in this clinical trial (owner or legal representative)\n\nExclusion Criteria:\n\nWho have not been diagnosed with malignant blood diseases (acute myelogenous leukemia, acute lymphocytic leukemia, non-Hodgkins lymphoma, Hodgkins lymphoma, multiple myelopathy) within 5 years of screening criteria\nPatients with severe aplastic anemia\nPatients with solid cancers in their previous medical history (within 5 years)\nPatients whose blood serum AST/ASL rates are more than three times the normal maximum rate, and whose creatinine rates are more than 1.5 times the normal maximum rate (but AST in myocardial infarction patients can temporarily rise, thus, as decided by the researchers, if there is no damage to the liver function, the rise will not be taken into consideration)\nPatients who have implemented Coronary Artery Bypass Graft(CABG)\nPatients with chronic heart failure (patients with medical history of heart failure medical history at least three months before the occurrence of acute myocardial infarction)\nPatients who cannot proceed with cardiac catheterization\nPatients who had been continuously taking large doses of steroids (1mg/kg/day) or antibiotics for severe infections from one month prior to registration\nPatients who had major surgical operations, organ biopsy, or significant external injury as determined by the researcher, within three months before registration\nPatients who have head injuries or other external injuries after the development of myocardial infarction\npatients with stroke or transient ischemic attack within six months before registration, patients with history of central nervous system disease (tumor, aneurysm, brain surgery etc.)\nPatients with low survival ability after cardiopulmonary resuscitation within last 2 weeks.\nPatients with positive for HIV, HBV, HCV, Syphilis\npregnant women or likely to be pregnant or lactating women\nPatients with drug abuser within last 1 year.\nPatients with participating other clinical trials with last 1 month.\nWhen the possibility of tumor occurrence is seen when the tester judges even one of the tumor marker tests during screening\nWho are judged to be inappropriate to participate in this test when judged by the examiner"
      ],
      "EnrollmentCount": [
            "90"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "Single dose of Hearticellgram-AMI"
      ],
      "InterventionBrowseBranchAbbrev": [
            "FiAg",
            "AnCoag",
            "All",
            "Antipy",
            "Infl",
            "ARhu",
            "Analg",
            "PlAggInh",
            "Lipd",
            "Infe",
            "ANeo"
      ],
      "InterventionBrowseBranchName": [
            "Fibrinolytic Agents",
            "Anticoagulants",
            "All Drugs and Chemicals",
            "Antipyretics",
            "Anti-Inflammatory Agents",
            "Antirheumatic Agents",
            "Analgesics",
            "Platelet Aggregation Inhibitors",
            "Lipid Regulating Agents",
            "Anti-Infective Agents",
            "Antineoplastic Agents"
      ],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [
            "M8733",
            "M3700",
            "M1669",
            "M8731",
            "M45326",
            "M19305",
            "M1943",
            "M6563",
            "M20308",
            "M3286",
            "M28069",
            "M2823",
            "M273811",
            "M15898"
      ],
      "InterventionBrowseLeafName": [
            "Heparin, Low-Molecular-Weight",
            "Aspirin",
            "Clopidogrel",
            "Heparin",
            "Calcium heparin",
            "Dalteparin",
            "Tinzaparin",
            "Diuretics",
            "Hydroxymethylglutaryl-CoA Reductase Inhibitors",
            "Angiotensin-Converting Enzyme Inhibitors",
            "Angiotensin Receptor Antagonists",
            "Adrenergic beta-Antagonists",
            "polysaccharide-K",
            "Ticlopidine"
      ],
      "InterventionBrowseLeafRelevance": [
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "InterventionDescription": [],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "Hearticellgram-AMI"
      ],
      "InterventionOtherName": [
            "(Autologous bone marrow derived mesenchymal stem cells)"
      ],
      "InterventionType": [
            "Biological"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "October 22, 2021"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "October 21, 2021"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "Pharmicell Co., Ltd."
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Chuncheon",
            "Chungnam",
            "Gwangju",
            "Gyeonggi-do",
            "Incheon",
            "Incheon",
            "Seoul",
            "Seoul",
            "Seoul",
            "W\u014fnju"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [
            "Bongki Lee",
            "Jin-ok Jeong",
            "Young Geun Ahn",
            "Duk-gyu Cho",
            "Jeonghan Yoon"
      ],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact",
            "Contact",
            "Contact",
            "Contact",
            "Contact"
      ],
      "LocationCountry": [
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of",
            "Korea, Republic of"
      ],
      "LocationFacility": [
            "Kangwon National University Hospital",
            "Chungnam National University Hospital",
            "Chonnam National University Hospital",
            "Yongin Severance Hospital",
            "Gachon University Gil Medical Center",
            "Inha University Hospital",
            "Catholic University of Korea, Seoul ST. Mary's Hospital.",
            "Korea University Medicine",
            "Severance Hospital, Yonsei University College of Medicine",
            "Wonju Severance Christian Hospital"
      ],
      "LocationState": [],
      "LocationStatus": [
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Recruiting",
            "Terminated",
            "Terminated",
            "Terminated",
            "Terminated",
            "Terminated",
            "Recruiting"
      ],
      "LocationZip": [],
      "MaximumAge": [
            "75 Years"
      ],
      "MinimumAge": [
            "20 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "A Randomized,Open labEled, muLticenter Trial for Safety and Efficacy of Intracoronary Adult Human Mesenchymal stEm Cells Acute Myocardial inFarction"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "Pharmicell Co., Ltd."
      ],
      "OrgStudyId": [
            "PMC-BD-CT-P-003"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "Wonju Severance Christian Hospital"
      ],
      "OverallOfficialName": [
            "Jeonghan Yoon, Ph.D. M.D."
      ],
      "OverallOfficialRole": [
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Recruiting"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 3"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "August 31, 2022"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "Left ventricle ejection fraction (LVEF) measured 13 months after the cell treatment (MRI measurement)"
      ],
      "PrimaryOutcomeMeasure": [
            "LVEF amount of change"
      ],
      "PrimaryOutcomeTimeFrame": [
            "13 months after the cell treatment"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [
            "Left ventricle ejection fraction (LVEF) measured 6 months after the cell treatment (MRI measurement)",
            "Change in infarct size evaluated by MRI at 6 and 13 months compared to before administration",
            "Change in left ventricular end systolic size evaluated by MRI at 6 months and 13 months compared to before administration",
            "Change in left ventricular end diastolic size evaluated by MRI at 6 months and 13 months compared to before administration",
            "The incidence of major cardiac events (death, hospitalization for cardiac shock or heart failure, recurrence of myocardial infarction, occurrence of severe arrhythmias) within 24 months after administration",
            "Heart rate variability change at 13 months compared to before administration (24 hours Holter measurement)",
            "The amount of change in the left ventricular local wall movement impairment index evaluated by echocardiography at 6 and 13 months compared to before administration",
            "Changes in N-terminal pro-brain natriuretic peptide (NT-proBNP) at 6 and 13 months compared to before administration"
      ],
      "SecondaryOutcomeMeasure": [
            "LVEF amount of change",
            "Infarct size amount of change",
            "Left ventricle end systolic size change",
            "Left ventricular end-diastolic size change",
            "Incidence of critical heart events",
            "Heart rate variability change amount",
            "Left ventricular local wall movement disorder index change",
            "N-terminal pro-brain natriuretic peptide (NT-proBNP) change"
      ],
      "SecondaryOutcomeTimeFrame": [
            "6 months after the cell treatment",
            "6, 13 months after the cell treatment",
            "6, 13 months after the cell treatment",
            "6, 13 months after the cell treatment",
            "Within 24 months after the cell treatment",
            "13 months after the cell treatment",
            "6, 13 months after the cell treatment",
            "6, 13 months after the cell treatment"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "September 1, 2013"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "October 2021"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "July 27, 2012"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "July 25, 2012"
      ],
      "StudyFirstSubmitQCDate": [
            "July 25, 2012"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}